Y-mAbs Therapeutics, Inc. (YMAB) Investor Alert: Robbins

SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all...

Related Keywords

Germany ,San Diego ,California ,United States ,German ,Aaron Dumas ,Y Mabs Therapeutic Inc ,Y Mabs Therapeutics Inc ,Advisory Committee Meeting ,Securities Exchange ,Nasdaq ,Memorial Sloan Kettering Cancer Center ,Y Mabs Therapeutics ,Securities Exchange Act ,Case About ,Lead Drug ,Biologics License Application ,Central German Childhood Cancer Registry ,Briefing Document ,Committee Meeting ,Y Mabs Therapeutic ,Robbins Llp ,Smab ,Y Mabs Clinical Trials ,Y Mabs Shareholders ,Y Mabs Stock Drop ,Investor ,Fraud ,Attorney ,Lass Action ,